Skip to main content

COVID-19 Vaccination May Increase Risk for Urinary Tract Symptoms

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 1, 2024.

via HealthDay

THURSDAY, Aug. 1, 2024 -- COVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.

Marta de-la-Plaza-San-Frutos, from Universidad Europea de Madrid in Spain, and colleagues examined potential side effects of COVID-19 vaccination on the urinary tract among 1,563 individuals (74.7 percent women and 27.3 percent men), aged 18 to 45 years, who completed an online survey.

The researchers found that the Pfizer-BioNTech vaccine was the most frequently administered vaccine type (42.2 percent), and most individuals received three doses. The proportion of individuals who received the AstraZeneca vaccine and did not need to urinate in the night was significantly higher for women than men (59.1 versus 33.3 percent). Compared with those who received three vaccine doses, a higher proportion of those who received a single dose urinate five or more times during the night (2.2 versus 0.1 percent).

"Based on the results obtained in this study, monitoring and addressing urinary tract side effects of COVID-19 vaccination are important for vaccination programs to include the systematic collection of urinary tract side effect data, which will allow for ongoing evaluation of vaccine safety and efficacy," the authors write. "Health care professionals should be alert to the possibility of patients experiencing urinary tract symptoms following COVID-19 vaccination."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab

TUESDAY, July 22, 2025 -- Despite near universal availability of nirsevimab, only 35 percent of eligible children receive nirsevimab for respiratory syncytial virus (RSV)...

2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults

FRIDAY, July 18, 2025 -- There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS...

No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines

TUESDAY, July 15, 2025 -- Early childhood exposure to aluminum-adsorbed vaccines is not associated with an increased risk for autoimmune, atopic or allergic, or neurodevelopmental...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.